Who Exports Spironolactone from India — 259 Suppliers Behind a $197.4M Market
India's spironolactone export market is supplied by 259 active exporters who collectively shipped $197.4M across 5,262 shipments. ZYDUS LIFESCIENCES LIMITED leads with a 54.1% market share, followed by AMNEAL PHARMACEUTICALS PRIVATE LIMITED and AUROBINDO PHARMA LTD. The top 5 suppliers together control 90.2% of total export value, reflecting a concentrated market structure.
Top Spironolactone Exporters from India — Ranked by Export Value
ZYDUS LIFESCIENCES LIMITED is the leading spironolactone exporter from India, holding a 54.1% share of the $197.4M market across 5,262 shipments from 259 exporters. The top 5 suppliers — ZYDUS LIFESCIENCES LIMITED, AMNEAL PHARMACEUTICALS PRIVATE LIMITED, AUROBINDO PHARMA LTD, INTAS PHARMACEUTICALS LIMITED, AUROBINDO PHARMA LIMITED — collectively control 90.2% of total export value, indicating a highly concentrated market. Individual shares are: ZYDUS LIFESCIENCES LIMITED (54.1%), AMNEAL PHARMACEUTICALS PRIVATE LIMITED (19.4%), AUROBINDO PHARMA LTD (6.9%), INTAS PHARMACEUTICALS LIMITED (6.2%), AUROBINDO PHARMA LIMITED (3.6%).
Top Spironolactone Exporters from India
Ranked by export value · 259 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | ZYDUS LIFESCIENCES LIMITED SPIRONOLACTONE TABLETS 50MG 1X500 PACKS)SPIRONOLACTONE TABLETS 50MG 1X100 PACKS) | $106.7M | 3 | 54.1% |
| 2 | AMNEAL PHARMACEUTICALS PRIVATE LIMITED SPIRONOLACTONE TABLETS 50MG 1X500 PACKS)SPIRONOLACTONE TABLETS 50MG 1X100 PACKS) | $38.4M | 1 | 19.4% |
| 3 | AUROBINDO PHARMA LTD SPIRONOLACTONE TABLETS 50MG 1X500 PACKS)SPIRONOLACTONE TABLETS 50MG 1X100 PACKS) | $13.6M | 1 | 6.9% |
| 4 | INTAS PHARMACEUTICALS LIMITED PHARMA DRUGS & MEDI SPIRONOLACTONE 50MG1PHARMA DRUGS & MEDI SPIRONOLACTONE 25MG1 | $12.2M | 9 | 6.2% |
| 5 | AUROBINDO PHARMA LIMITED SPIRONOLACTONE TABLETS 50MG 1X500 PACKS)SPIRONOLACTONE TABLETS 50MG 1X100 PACKS) | $7.2M | 1 | 3.6% |
| 6 | CADILA HEALTHCARE LIMITED SPIRONOLACTONE TABLETS 50MG 1X500 PACKS)SPIRONOLACTONE TABLETS 50MG 1X100 PACKS) | $4.7M | 1 | 2.4% |
| 7 | PIRAMAL PHARMA LIMITED PHARMA DRUGS & MEDI SPIRONOLACTONE 50MG1PHARMA DRUGS & MEDI SPIRONOLACTONE 25MG1SPIRONOLACTONE 100 MG TABLETS 2X14`S | $2.4M | 2 | 1.2% |
| 8 | COHANCE LIFESCIENCES LIMITED SPIRONOLACTONE TABLETS 50MG 1X500 PACKS)SPIRONOLACTONE TABLETS 50MG 1X100 PACKS)SPIRONOLACTONE TABLETS USP 25MG | $1.6M | 2 | 0.8% |
| 9 | FREDUN PHARMACEUTICALS LTD SPIROFAR-25 TABLET(SPIRONOLACTONEPHARMACEUTICAL PRODUCTS: SPIRE QTY:33540X3X10SNOSSPIROFAR | $1.4M | 2 | 0.7% |
| 10 | CADILA HEALTHCARE LTD SPIRONOLACTONE TABLETS 50MG 1X500 PACKS)SPIRONOLACTONE TABLETS 50MG 1X100 PACKS) | $1.2M | 1 | 0.6% |
| 11 | STERIL-GENE LIFE SCIENCES PRIVATE LIMITED SPIRONOLACTONE 100 MG TABLETS 2X14`SSPIRONOLACTONE 100 MG TABLETSSPIRONOLACTONE 50MG TABS PVCBL 2X14S | $730.6K | 1 | 0.4% |
| 12 | GRACURE PHARMACEUTICALS LIMITED SPIRONOLACTONE TABLETS USP 25MGJAMP SPIRONOLACTONE (SPIRONOLACTONE TABL | $584.7K | 1 | 0.3% |
| 13 | ATOZ PHARMACEUTICALS PRIVATE LIMITED SPIRONOLACTONE 50 MG + HYDROCHLORTHIAZIDTABLET SPIRONOLACTONE TAB BP 25 MG | $574.1K | 1 | 0.3% |
| 14 | UNICURE REMEDIES PRIVATE LIMITED SPIROFAR-25 TABLET(SPIRONOLACTONEPHARMACEUTICAL PRODUCTS: SPIRE QTY:33540X3X10SNOSSPIROFAR | $518.5K | 5 | 0.3% |
| 15 | MAXTAR BIO GENICS SPIROFAR-25 TABLET(SPIRONOLACTONEPHARMACEUTICAL PRODUCTS: SPIRE QTY:33540X3X10SNOSSPIROFAR | $426.1K | 1 | 0.2% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Spironolactone exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| ZYDUS LIFESCIENCES LIMITED | Warning Letter (August 20 | Unknown | Unknown | Not verified | Received FDA warning letter for CGMP violations; closeout letter issued December |
| AUROBINDO PHARMA LIMITED | Warning Letter (June 2019 | Unknown | Unknown | Not verified | FDA warning letter for CGMP deviations in API manufacturing. |
| INTAS PHARMACEUTICALS LIMITED | Approved | Yes, April 2007 | Yes | Not verified | EU GMP certification received in April 2007; FDA approvals for various products. |
| CADILA PHARMACEUTICALS LIMITED | Warning Letter (March 201 | Yes | Unknown | Not verified | FDA warning letter for manufacturing practice discrepancies; WHO-GMP compliant f |
TransData Nexus reviewed the regulatory standing of 4 leading Spironolactone exporters from India. 1 hold US FDA facility approvals, 2 maintain WHO-GMP certification, and 1 are EU GMP compliant. 3 suppliers have received FDA regulatory actions — buyers should verify current remediation status before placing orders. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Spironolactone sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as the "Bulk Drug Capital of India," contributes over 40% to the nation's bulk drug production. This prominence is bolstered by the Hyderabad Pharma City project, recognized as a National Investment Manufacturing Zone (NIMZ) in December 2019, underscoring its strategic importance. The city's pharmaceutical landscape is characterized by a robust ecosystem of bulk drug manufacturers, including companies like A.R. Life Sciences, which specializes in active pharmaceutical ingredients (APIs) and intermediates. This concentration of bulk drug production facilities positions Hyderabad as a pivotal hub for sourcing APIs essential for formulations like Spironolactone.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is renowned for its pharmaceutical formulations industry. Vadodara, in particular, hosts numerous pharmaceutical companies specializing in the production of finished dosage forms. For instance, Wellmed Pharma in Vadodara offers a comprehensive range of pharmaceutical products, including tablets, syrups, and injectables, adhering to GMP and WHO standards. This region's focus on formulations makes it a strategic location for sourcing finished Spironolactone products.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad belt serves as a critical export gateway for India's pharmaceutical industry. Mumbai, being a major port city, facilitates the export of pharmaceutical products to global markets. Companies like Formel Labs, with facilities in Mumbai, are committed to producing high-quality pharmaceuticals and have established themselves as reliable partners in the global supply chain. This region's infrastructure and connectivity make it an advantageous point for exporting Spironolactone formulations to international destinations.
4Baddi-Nalagarh — Tax Incentive Zone
The Baddi-Nalagarh region in Himachal Pradesh is known for its tax incentives, attracting numerous pharmaceutical manufacturers. Companies like Theon Pharma, based in Baddi, offer contract manufacturing services across India, including Gujarat. This region's favorable tax policies and established manufacturing facilities make it a cost-effective option for producing Spironolactone formulations.
5Sourcing Recommendations
- Leverage Hyderabad's API Production: Utilize Hyderabad's extensive bulk drug manufacturing capabilities to source high-quality Spironolactone APIs, ensuring a reliable supply chain.
- Partner with Vadodara Formulation Units: Collaborate with Vadodara-based companies specializing in pharmaceutical formulations to access finished Spironolactone products that meet international quality standards.
- Utilize Mumbai's Export Infrastructure: Take advantage of Mumbai's strategic location and export facilities to efficiently distribute Spironolactone products to global markets.
- Consider Baddi for Cost-Effective Manufacturing: Explore manufacturing partnerships in the Baddi-Nalagarh region to benefit from tax incentives and reduce production costs for Spironolactone formulations.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Spironolactone exporters from India
Aurobindo Pharma Limited — Aurobindo's TheraNym Biologics partners with Merck for biologics manufacturing
TheraNym Biologics, a wholly owned subsidiary of Aurobindo Pharma, signed an agreement with Merck & Co. to expand its biologics manufacturing facilities and explore contract manufacturing operations for biologics. - IMPACT: This collaboration is expected to enhance Aurobindo's production capabilities, potentially increasing Spironolactone exports.
Impact: This collaboration is expected to enhance Aurobindo's production capabilities, potentially increasing Spironolactone exports.
Zydus Lifesciences Limited — Cadila Healthcare rebrands as Zydus Lifesciences
Cadila Healthcare Limited officially changed its name to Zydus Lifesciences Limited to reflect its evolving business focus. - IMPACT: The rebranding may influence market perception and branding of Spironolactone products.
Impact: The rebranding may influence market perception and branding of Spironolactone products.
Intas Pharmaceuticals Limited — Intas acquires Teva's UK and Ireland assets for $764 million
Intas Pharmaceuticals acquired the UK and Ireland assets of Teva Pharmaceuticals, enhancing its European market presence. - IMPACT: This acquisition could lead to increased Spironolactone exports to European markets.
Impact: This acquisition could lead to increased Spironolactone exports to European markets.
Common Questions — Spironolactone Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which spironolactone supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, ZYDUS LIFESCIENCES LIMITED leads with 262 recorded shipments worth $106.7M. AMNEAL PHARMACEUTICALS PRIVATE LIMITED (373 shipments) and AUROBINDO PHARMA LTD (167 shipments) are also established high-volume exporters.
Q How many spironolactone manufacturers are there in India?
India has 259 active spironolactone exporters with a combined export market of $197.4M across 5,262 shipments to 112 countries. The top 5 suppliers hold 90.2% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for spironolactone from India?
Average FOB unit price: $7.21 per unit, ranging from $0.00 to $5929.79. Average shipment value: $37.5K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 259 verified Indian exporters of Spironolactone ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 5,262 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 112 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
5,262 Verified Shipments
259 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists